Technical Analysis for BCT - Briacell Therapeutics Corp.

Grade Last Price % Change Price Change
D 1.090 28.24% 0.240
BCT closed up 28.24 percent on Thursday, November 21, 2024, on 1.12 times normal volume. The stock rose above its 50 day moving average, improving its intermediate-term outlook by crossing above that important trendline.
Earnings due: Dec 12
*** please verify all earnings dates ***
0 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Up Up

Date Alert Name Type % Chg
Crossed Above 20 DMA Bullish 0.00%
Crossed Above 50 DMA Bullish 0.00%
Expansion Pivot Buy Setup Bullish Swing Setup 0.00%
Wide Range Bar Range Expansion 0.00%
Wide Bands Range Expansion 0.00%
Gapped Up Strength 0.00%
Oversold Stochastic Weakness 0.00%
Bullish Engulfing Bullish 28.24%
Wide Bands Range Expansion 28.24%
Oversold Stochastic Weakness 28.24%

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Briacell Therapeutics Corp. Description

BriaCell Therapeutics Corp. is an immuno-oncology biotechnology company. The Company is engaged in the research and development of cancer immunotherapy technology. The Company offers BriaVax, an immunotherapy vaccine. The Company is engaged in developing and advancing its BriaVax immunotherapy vaccine for patients with advanced breast cancer. The Company is also engaged in the research and development of its companion diagnostic product, BriaDx. The Company's BriaDx program is focused on analyzing samples obtained from patients previously treated with BriaVax along with co-analysis of previously manufactured vaccine lots. The Company's analysis methods include various technologies, including gene expression profiling by Illumina microarrays and human leukocyte antigen (HLA) typing by a high-resolution method. The Company is focused on understanding the mechanism of action (MoA) of BriaVax.


Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biotechnology Cancer Medical Specialties Therapy Oncology Immunology Antigen Immunotherapy Cancer Immunotherapy Biotechnology Companies Breast Cancer Vaccine

Is BCT a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 8.0
52 Week Low 0.64
Average Volume 65,525
200-Day Moving Average 2.342
50-Day Moving Average 1.027
20-Day Moving Average 0.987
10-Day Moving Average 0.886
Average True Range 0.109
RSI (14) 55.16
ADX 19.64
+DI 35.511
-DI 24.420
Chandelier Exit (Long, 3 ATRs) 0.995
Chandelier Exit (Short, 3 ATRs) 1.106
Upper Bollinger Bands 1.255
Lower Bollinger Band 0.718
Percent B (%b) 0.69
BandWidth 54.455
MACD Line -0.062
MACD Signal Line -0.061
MACD Histogram -0.0007
Fundamentals Value
Market Cap 841.44 Thousand
Num Shares 772 Thousand
EPS -0.04
Price-to-Earnings (P/E) Ratio -28.68
Price-to-Sales 0.00
Price-to-Book 10.01
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 1.420
Resistance 3 (R3) 1.393 1.257 1.365
Resistance 2 (R2) 1.257 1.173 1.270 1.347
Resistance 1 (R1) 1.173 1.121 1.215 1.200 1.328
Pivot Point 1.037 1.037 1.058 1.050 1.037
Support 1 (S1) 0.953 0.953 0.995 0.980 0.852
Support 2 (S2) 0.817 0.901 0.830 0.833
Support 3 (S3) 0.733 0.817 0.815
Support 4 (S4) 0.760